5 results
Fremanezumab for the Preventive Treatment of Chronic Migraine - Primary and Secondary End Points #EBM #Neuro
End Points #EBM #Neuro ... #IM #Fremanezumab ... #Migraine #CGRP ... CalcitoninGeneRelatedPeptideAntibody #Results #NEJM ... #NEJM
Fremanezumab for the Preventive Treatment of Chronic Migraine - Adverse Events in the Safety Population, According
Trial Group #EBM #Neuro ... #IM #Fremanezumab ... #Migraine #CGRP ... AdverseEvents #NEJM ... #NEJM
Fremanezumab for the Preventive Treatment of Chronic Migraine - Primary and Secondary End Points #EBM #Neuro
Treatment of Chronic Migraine ... End Points #EBM #Neuro ... #IM #Fremanezumab ... #Migraine #CGRP ... CalcitoninGeneRelatedPeptideAntibody #NEJM
Kinetics of Viral and Serologic Responses after Exposure to West Nile Virus. #Diagnosis #IM #InfectiousDisease #WestNile
#Diagnosis #IM # ... InfectiousDisease ... IgM #Detection #NEJM
A 48-year-old-man presented to the dermatology clinic with a whitish discoloration and hyperkeratosis of the first
#Clinical #IM #InfectiousDisease ... RapidProgression #NEJM